Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.50 |
| ▸ | AR | P10275 | 11/20 | 0.41 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.41 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.37 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.36 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20111536 | 0.86 | ALOX5AP (0.47) | KIF11ARPDE3BPDE3AALOX5AP | |
| SCHEMBL25658384 | 0.84 | KIF11 (0.54) | KIF11ARTRPV4PDE3BPDE3A | |
| SCHEMBL20616789 | 0.82 | AR (0.61) | KIF11ARALOX5APFEN1PGR | |
| SCHEMBL28668535 | 0.78 | KIF11 (0.57) | KIF11ARTRPV4PGRCYP11B2 | |
| SCHEMBL25658407 | 0.78 | KIF11 (0.46) | KIF11ARTRPV4PGR | |
| SCHEMBL7604551 | 0.78 | TRPV4 (0.56) | KIF11ARTRPV4 | |
| SCHEMBL17955138 | 0.77 | KIF11 (0.53) | KIF11ARTRPV4PDE3BPDE3A | |
| SCHEMBL25658402 | 0.77 | KIF11 (0.45) | KIF11ARTRPV4PGR | |
| SCHEMBL25658487 | 0.77 | FEN1 (0.57) | KIF11ARALOX5APFEN1ESR1 | |
| SCHEMBL2371259 | 0.75 | AR (0.47) | KIF11ARTRPV4PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11825743-B2 | Organic molecules for use in organic optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-21 | — | — | US | disclosed |
| EP-3585777-B1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2023-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11825743-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, OCIAD2 | KIF11 3288/4885AR 4630/4885TRPV4 243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.